Details of the Drug

General Information of Drug (ID: DMK7WON)

Drug Name
2-morpholino-7-phenyl-4H-chromen-4-one
Synonyms CHEMBL95309
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 307.3
Logarithm of the Partition Coefficient (xlogp) 3.1
Rotatable Bond Count (rotbonds) 2
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C19H17NO3
IUPAC Name
2-morpholin-4-yl-7-phenylchromen-4-one
Canonical SMILES
C1COCCN1C2=CC(=O)C3=C(O2)C=C(C=C3)C4=CC=CC=C4
InChI
InChI=1S/C19H17NO3/c21-17-13-19(20-8-10-22-11-9-20)23-18-12-15(6-7-16(17)18)14-4-2-1-3-5-14/h1-7,12-13H,8-11H2
InChIKey
RWIGISKNQAMRJZ-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
23586694
TTD ID
D0MJ1L

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Phosphodiesterase 3A (PDE3A) TT06AWU PDE3A_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Phosphodiesterase 3A (PDE3A) DTT PDE3A 3.33E-01 1.35E-02 0.14
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Analysis of anti-PDE3 activity of 2-morpholinochromone derivatives reveals multiple mechanisms of anti-platelet activity. Bioorg Med Chem Lett. 2006 Feb 15;16(4):969-73.